GlaxoSmithKline plc (LON:GSK) had its target price raised by investment analysts at Jefferies Group from GBX 1,900 ($23.51) to GBX 1,950 ($24.13) in a research report issued on Thursday. The firm currently has a “buy” rating on the stock. Jefferies Group’s price objective points to a potential upside of 15.32% from the stock’s previous close.
Other research analysts have also issued research reports about the stock. Shore Capital restated a “hold” rating on shares of GlaxoSmithKline plc in a research report on Monday, June 20th. HSBC restated a “buy” rating and issued a GBX 1,970 ($24.38) price target on shares of GlaxoSmithKline plc in a research report on Monday, September 12th. Deutsche Bank AG restated a “hold” rating on shares of GlaxoSmithKline plc in a research report on Monday, June 27th. Berenberg Bank set a GBX 1,885 ($23.33) price target on shares of GlaxoSmithKline plc and gave the stock a “neutral” rating in a research report on Tuesday, August 9th. Finally, Beaufort Securities restated a “buy” rating on shares of GlaxoSmithKline plc in a research report on Tuesday, June 21st. Three investment analysts have rated the stock with a sell rating, fifteen have given a hold rating and eight have issued a buy rating to the company’s stock. GlaxoSmithKline plc has a consensus rating of “Hold” and a consensus target price of GBX 1,687.13 ($20.88).
GlaxoSmithKline plc (LON:GSK) opened at 1687.50 on Thursday. The company has a 50 day moving average price of GBX 1,650.69 and a 200 day moving average price of GBX 1,561.99. GlaxoSmithKline plc has a 12 month low of GBX 1,277.25 and a 12 month high of GBX 1,745.56. The stock’s market capitalization is GBX 82.03 billion.
The business also recently disclosed a dividend, which was paid on Thursday, October 13th. Stockholders of record on Thursday, August 11th were issued a dividend of GBX 19 ($0.24) per share. The ex-dividend date of this dividend was Thursday, August 11th. This represents a dividend yield of 1.12%.
In other news, insider Witty,Sir Andrew P sold 10,000 shares of the business’s stock in a transaction dated Wednesday, July 27th. The shares were sold at an average price of GBX 1,693 ($20.95), for a total transaction of £169,300 ($209,529.70). Also, insider Slaoui,Moncef acquired 28 shares of the company’s stock in a transaction dated Friday, August 12th. The shares were bought at an average price of GBX 2,208 ($27.33) per share, for a total transaction of £618.24 ($765.15).